Trabectedin Combined With Durvalumab in Patients With Advanced Pretreated Soft-tissue Sarcomas and Ovarian Carcinomas. (TRAMUNE)

NCT03085225 PHASE1 COMPLETED Results posted

A phase Ib trial study of trabectedin when prescribed in combination with durvalumab in locally advanced/unresectable soft-tissue sarcoma and ovarian carcinomas.

Details

Lead sponsor	Institut Bergonié
Phase	PHASE1
Status	COMPLETED
Enrolment	40
Start date	Fri May 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Tue Jan 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Ovarian Carcinoma
• Soft Tissue Sarcoma

Interventions

• Combination of trabectedin with durvalumab

Countries

France